Graham Foxon had a very informative 3 days at the HTAi annual meeting in Cologne, attending seminars on HTA and its dimensions, HTA beyond 2020 and Regulators vs Payers, among many other presentations.


Contact us to understand the concept of how HTA may be used to determine the price, reimbursement and/or access of a new pharmaceutical product, and find out how we can help you with your HTA submissions.